interferon-gamma links ultraviolet radiation melanomagenesis mice
cutaneous malignant melanoma highly aggressive frequently chemoresistant cancer incidence continues rise epidemiological studies show major aetiological melanoma risk factor ultraviolet uv solar radiation highest risk associated intermittent burning doses especially childhood experimentally validated epidemiological findings using hepatocyte growth factor/scatter factor transgenic mouse model develops lesions stages highly reminiscent human melanoma respect biological genetic aetiological criteria irradiated neonatal pups uvb uva however mechanisms underlying uvb-initiated neonatal-specific melanomagenesis remain largely unknown introduce mouse model permitting fluorescence-aided melanocyte imaging isolation following vivo uv irradiation use expression profiling show activated neonatal skin melanocytes isolated following melanomagenic uvb dose bear distinct persistent interferon response signature including genes associated immunoevasion uvb-induced melanocyte activation characterized aberrant growth migration abolished antibody-mediated systemic blockade interferon-gamma ifn-gamma type-i interferons ifn-gamma produced macrophages recruited neonatal skin uvb-induced ligands chemokine receptor ccr2 admixed recruited skin macrophages enhanced transplanted melanoma growth inhibiting apoptosis notably ifn-gamma blockade abolished macrophage-enhanced melanoma growth survival ifn-gamma-producing macrophages also identified % human melanomas examined data reveal unanticipated role ifn-gamma promoting melanocytic cell survival/immunoevasion identifying novel candidate therapeutic target subset melanoma patients
